Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer

NCT02991196 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Colorectal Neoplasm

Interventions

DRUG: DS-8273a + nivolumab

Sponsor

Daiichi Sankyo

Collaborators

[object Object]